A Single Center, Open Label, Fixed Sequence, Two-Period Study to Investigate the Effect of Multiple Dose Valproate on the Pharmacokinetics of Ro4917838 and Vice Versa in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2016
At a glance
- Drugs Bitopertin (Primary) ; Valproic acid
- Indications Epilepsy; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Roche
- 15 Aug 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 06 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Dec 2011 New trial record